Declines in dietary macronutrient intake in persons with HIV infection who develop depression

Public Health Nutrition

Volumn 11, Issue 2, 2008, Pages 124-131

  Isaac, Rita ^a   Jacobson, Denise ^a   Wanke, Christine ^a   Hendricks, Kristy ^a   Knox, Tamsin A ^a,b   Wilson, Ira B ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Depression; Dietary intake; HIV; Nutrition

Indexed keywords

ADULT; AGE; ARTICLE; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; DEPRESSION; DIETARY INTAKE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; DEPRESSIVE DISORDER; DIET; DIET RECORDS; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; NUTRITIONAL STATUS; PSYCHIATRIC STATUS RATING SCALES; SURVIVORS; VIRAL LOAD;

EID: 38149100195     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980007000067     Document Type: Article

References (42)

1. Wanke CA, Silva M, Knox TA, Forrester J, Spiegelman D, Gorbach SL. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clinical Infectious Diseases 2000; 31(3): 803-5.
2. Tang AM. Weight loss, wasting, and survival in HIV-positive patients: current strategies. The AIDS Reader 2003; 13(12 Suppl.): S23-7.
3. Tang AM, Forrester J, Spiegelman D, Knox TA, Tchetgen E, Gorbach SL. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 2002; 31(2): 230-6.
4. Arnalich F, Martinez P, Hernanz A, Gonzalez J, Plaza MA, Montiel C, et al. Altered concentrations of appetite regulators may contribute to the development and maintenance of HIV-associated wasting. AIDS 1997; 11(9): 1129-34.
5. Tang AM, Jacobson DL, Spiegelman D, Knox TA, Wanke C. Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003. Journal of Acquired Immune Deficiency Syndromes 2005; 40(1): 70-6.
6. Melchior JC, Niyongabo T, Henzel D, Durack-Bown I, Henri SC, Boulier A. Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients. Nutrition 1999; 15(11-12): 865-9.
7. Shevitz AH, Knox TA, Spiegelman D, Roubenoff R, Gorbach SL, Skolnik PR. Elevated resting energy expenditure among HIV-seropositive persons receiving highly-active antiretroviral therapy. AIDS 1999; 13(11): 1351-7.
8. Jacobson DL, Bica I, Knox TA, Wanke C, Tchetgen E, Spiegelman D, et al. Difficulty swallowing and lack of receipt of highly active antiretroviral therapy predict acute weight loss in human immunodeficiency virus disease. Clinical Infectious Diseases 2003; 37(10): 1349-56.
9. Carbonnel F, Beaugerie L, Abou RA, D'Almagne H, Rozenbaum W, Le QY, et al. Macronutrient intake and malabsorption in HIV infection: a comparison with other malabsorptive states. Gut 1997; 41(6): 805-10.
10. Cruess DG, Evans DL, Repetto MJ, Gettes D, Douglas SD, Petitto JM. Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease. Biological Psychiatry 2003; 54(3): 307-16.
11. Christensen L, Somers S. Comparison of nutrient intake among depressed and nondepressed individuals. International Journal of Eating Disorders 1996; 20(1): 105-9.
12. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. Journal of Affective Disorders 1998; 48(2-3): 149-55.
13. Peet M. International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis. British Journal of Psychiatry 2004; 184: 404-8.
14. Morris MS, Fava M, Jacques PF, Selhub J, Rosenberg IH. Depression and folate status in the US population. Psychotherapy and Psychosomatics 2003; 72(2): 80-7.
15. Rosche J, Uhlmann C, Froscher W. Low serum folate levels as a risk factor for depressive mood in patients with chronic epilepsy. Journal of Neuropsychiatry and Clinical Neurosciences 2003; 15(1): 64-6.
16. Bottiglieri T, Hyland K, Laundy M, Godfrey P, Carney MW, Toone BK, et al. Folate deficiency, biopterin and monoamine metabolism in depression. Psychological Medicine 1992; 22(4): 871-6.
17. Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, Podell ER, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. New England Journal of Medicine 1988; 318(26): 1720-8.
18. Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Medical Care 1988; 26(8): 775-89.
19. Stewart AL, Ware JE, eds. Measuring Function and Well-Being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press, 1992.
20. Radloff LN. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977; 1: 385.
21. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. American Journal of Epidemiology 1977; 106(3): 203-14.
22. Myers JK, Weissman MM. Use of a self-report symptom scale to detect depression in a community sample. American Journal of Psychiatry 1980; 137(9): 1081-4.
23. Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Wisniewski SR, Fava M, et al. Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA: Journal of the American Medical Association 2006; 295(12): 1389-98.
24. Robins LN, Helzer JE, Ratcliff KS, Seyfried W. Validity of the diagnostic interview schedule, version II: DSM-III diagnoses. Psychological Medicine 1982; 12(4): 855-70.
25. Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Archives of General Psychiatry 1981; 38(4): 381-9.
26. Sherman AM. Social relations and depressive symptoms in older adults with knee osteoarthritis. Social Science & Medicine 2003; 56(2): 247-57.
27. Ahluwalia JS, Richter K, Mayo MS, Ahluwalia HK, Choi WS, Schmelzle KH, et al. African American smokers interested and eligible for a smoking cessation clinical trial: predictors of not returning for randomization. Annals of Epidemiology 2002; 12(3): 206-12.
28. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA: Journal of the American Medical Association 2002; 287(5): 591-7.
29. Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. Journal of Family Practice 2002; 51(3): 229-35.
30. Foy CG, Wickley KL, Adair N, Lang W, Miller ME, Rejeski WJ, et al. The Reconditioning Exercise and Chronic Obstructive Pulmonary Disease Trial II (REACT II): rationale and study design for a clinical trial of physical activity among individuals with chronic obstructive pulmonary disease. Contemporary Clinical Trials 2006; 27(2): 135-46.
31. Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, et al. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. Journal of the American Geriatrics Society 2005; 53(8): 1321-30.
32. Sivarajan Froelicher ES, Miller NH, Christopherson DJ, Martin K, Parker KM, Amonetti M, et al. High rates of sustained smoking cessation in women hospitalized with cardiovascular disease: the Women's Initiative for Nonsmoking (WINS). Circulation 2004; 109(5): 587-93.
33. Hays RD, Spritzer KL, McCaffrey D, Cleary PD, Collins R, Sherbourne C, et al. The HIV Cost and Services Utilization Study (HCSUS) Measures of Health-Related Quality of Life. DRU-1997-AHCPR. Santa Monica, CA: RAND Corporation, 1998.
34. Rothman K, Greenland S. Modern Epidemiology. Philadelphia, PA: Lippincott Williams & Wilkins, 1998.
35. Robins JM, Greenland S. The role of model selection in causal inference from nonexperimental data. American Journal of Epidemiology 1986; 123(3): 392-402.
36. Azizi F, Esmaillzadeh A, Mirmiran P. Correlates of underand over-reporting of energy intake in Tehranians: body mass index and lifestyle-related factors. Asia Pacific Journal of Clinical Nutrition 2005; 14(1): 54-9.
37. Rennie KL, Jebb SA, Wright A, Coward WA. Secular trends in under-reporting in young people. British Journal of Nutrition 2005; 93(2): 241-7.
38. Kim J. The Correlates of Hunger and Reduced Dietary Intake in a Cohort of HIV-positive Adults of the Boston Area: A Cross Sectional Study with Analysis of Data Quality and Post-Recruitment Retention Rates. Boston, MA: Harvard School of Public Health, 2001.
39. Ferrando S, Evans S, Goggin K, Sewell M, Fishman B, Rabkin J. Fatigue in HIV illness: relationship to depression, physical limitations, and disability. Psychosomatic Medicine 1998; 60(6): 759-64.
40. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA: Journal of the American Medical Association 2001; 285(11): 1466-74.
41. Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein Jr W. Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. Annals of Epidemiology 1996; 6(5): 420-30.
42. Mayne TJ, Vittinghoff E, Chesney MA, Barrett DC, Coates TJ. Depressive affect and survival among gay and bisexual men infected with HIV. Archives of Internal Medicine 1996; 156(19): 2233-8.